Filana Therapeutics, Inc. (FLNA) Tops Q1 EPS by 10c

Filana Therapeutics, Inc. (NASDAQ: FLNA) reported Q1 EPS of ($0.21), $0.10 better than the analyst estimate of ($0.31).

For earnings history and earnings-related data on Filana Therapeutics, Inc. (FLNA) click here.

You May Also Be Interested In

• Hawaiian Electric trades at 8.8x P/E, but wildfire risk clouds value case
• Hewlett Packard Enterprise (HPE) call put ratio 2.2 calls to 1 put into quarter results
• Medtronic jumps on earnings beat and raised guidance